| Name | Title | Contact Details |
|---|
La Follette Elc And Wtr Dept is a La Follette, TN-based company in the Business Services sector.
Absolute ROI is a Las Vegas, NV-based company in the Business Services sector.
We are compliance technology specialists. Our platform is founded on broad experience and deep expertise; and our products increase efficiency and minimise risk by successfully combining big data technologies with AI and machine learning. It all adds up to the worlds first truly intelligent compliance platform. But tech is only half the story. Our intelligent approach is applied to underpin your policy, process and procedure, so you can focus on specific outcomes. The Napier platform is fast, scalable and easily configurable, as well as user-friendly. It rapidly strengthens your AML defences and trade compliance capabilities, while meeting your companys compliance obligations and challenges in any sector.
San-Aire is a Fort Worth, TX-based company in the Business Services sector.
Petauri is a pharmaceutical services platform founded in 2023 and based in Nashville, Tennessee. The company focuses on providing integrated commercialization solutions for life sciences companies throughout the therapeutic lifecycle. Led by CEO Dan Renick, who has over 30 years of experience in the healthcare industry, Petauri aims to enhance clinical and economic value while accelerating the delivery of treatments to patients with unmet medical needs. The company offers a comprehensive range of services, including insights generation, medical and scientific communications, market access, and evidence-based solutions. Its U.S. Market Access activities are divided into three business units: Petauri Advisors, which provides pricing and market access consultancy; Petauri MAx, a strategic payer marketing agency; and Petauri Kinect, which focuses on engagement with health systems and hospitals. Petauri serves pharmaceutical and life sciences clients globally, helping them navigate complex healthcare ecosystems and optimize patient access to innovative therapies.